The test boast of rapid and accurate diagnosis with the following characteristics:
A total of 224 patient samples from susceptible subjects 4 were tested by the Dengue IgG/IgM Rapid Test and by a commercial EIA.
Relative Sensitivity: 95.8% , Relative Specificity: 97.5%, Overall Agreement: 97.3%
A total of 226 patient samples from susceptible subjects were tested by the Dengue IgG/IgM Rapid Test and by a commercial EIA.
|Product name||Dengue Ag+IgG/IgM Rapid Test|
|Place of Origin||Beijing, China|
|After-sale Service||Online technical support|
|Shelf Life||2 years|
|Quality Certification||ISO9001, ISO13485|
|Instrument classification||Class II|
|Package||1 test/bag. Card type：20tests/Kit,25 tests/Kit,40tests/Kit,50 tests/Kit,100tests/Kit.|
Packaging: 1pc/box; 25pcs/box, 50 pcs/box, 100pcs/box, individual aluminium foil bag package for each piece product; OEM packing is available.
Port: any ports of China, optional.
Beijing Jinwofu Bioengineering Technology Co., Ltd. focuses on high-quality in vitro diagnostic reagents. Through independent research and development, it has formed the core products of rapid in vitro diagnostic reagents with independent intellectual property rights: colloidal gold, latex rapid immune diagnostic reagent products, such as infectious disease detection series, eugenics and eugenics detection series, infectious disease detection products, etc.
Welcome to contact us for more information!